DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Motzer RJ, Escudier B, Powles T. et al.
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma.

Br J Cancer 2018;
118: 1176-1178

Download Bibliographical Data

Access:
Access:
Access: